Most research peptide supply asks buyers to trust a Certificate of Analysis they cannot independently check. AVODAGEN is built to remove that leap of faith.
We supply research-grade peptides, intermediates, and bioactive reagents to qualified business and institutional partners internationally. The model rests on four things a buyer can actually verify: GMP-compliant upstream sourcing, ISO 9001 certified Korean processing, independent accredited analytical verification, and batch-level documentation through our KORECOA platform. Pharmaceutical-grade engagements are available through custom development for qualified institutional partners by request. Research use only.
AVODAGEN Limited is the international B2B trading entity for our research peptide supply operation. Our Korean operating partner NovaBridge Co., Ltd. (BRN 579-87-03936, Seoul) is registered for chemical products wholesale including peptide supply (펩타이드를 포함 공급), and holds partnerships with a KOSDAQ-listed PIC/S GMP-certified peptide CDMO, KOSDAQ-listed accredited analytical laboratories, and Korean university research facilities.
Korean Gold Standard operating model: GMP-compliant upstream sourcing, ISO 9001 certified Korean processing through Korea's PIC/S GMP-certified peptide CDMO, accredited analytical verification, and KORECOA batch documentation. Built for institutional procurement standards.
The global peptide supply chain has a structural gap. Fragmented sourcing creates inconsistent documentation. European premium pricing locks out commercial buyers. Direct emerging-market sourcing fails institutional procurement review. AVODAGEN occupies the position between these alternatives: Korean processing infrastructure with accredited verification, at commercial terms, that holds up under institutional review.
Korean pharmaceutical standards align with International Council for Harmonisation expectations on documentation, batch records, and analytical methods.
KORUS Free Trade Agreement framework supports Korean origin qualification through real value-add chemistry, not transhipment.
Korea hosts accredited testing infrastructure suitable for institutional-grade verification. AVODAGEN leverages Korean accredited laboratory partnerships for independent third-party batch verification.
Korean-based infrastructure aligns with the global preference for diversified, documented, and verifiable biotech sourcing.
Founded by Peter Lee. US citizen, bilingual in Korean and English, based in Seoul. 22 years of operational discipline from entertainment post-production for Netflix, Apple TV+, IMAX, and BTS work — applied now to cross-border peptide supply where documentation that holds up to scrutiny matters most.
Korean tax accounting, regulatory counsel, and substantial transformation strategy support is in place.
Qualified institutional and commercial partners only. Business account verification required.
Request Qualified Partner Access →